AffaMed Therapeutics
PrivateLast Round
Series B
Mar 30, 2021
Total Funding Raised
$250M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AffaMed Therapeutics operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B round in March 2021.
AffaMed Therapeutics is a biopharmaceutical company that develops and commercializes transformative pharmaceutical products for ophthalmic, neurological, and psychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AffaMed Therapeutics Comparables
Compare AffaMed Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arctic Vision | 88% | |
| Allgenesis Biotherapeutics Inc. | 80% | |
| Ocumension Therapeutics | 78% |
For institutional investors. Book with your work email.
AffaMed Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 30, 2021 | ||||
| Series A | Feb 1, 2019 |
For institutional investors. Book with your work email.
AffaMed Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lake Bleu Capital | Series B |
| CBC Group | Series B, Series A |
| Superstring Capital Management | Series B |
| Fountainhead Partners | Series B |
| Partners Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 8, 4x the trailing average.
- Jul 20, 2026
Open roles increased from 0 to 8, representing 25% of headcount.
For institutional investors. Book with your work email.
AffaMed Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AffaMed Therapeutics's valuation, stock price, and market status.
Is AffaMed Therapeutics a public or private company?
AffaMed Therapeutics is a private company.
What is the current stock price of AffaMed Therapeutics?
AffaMed Therapeutics is a private company, so its shares have no public market price. Caplight tracks AffaMed Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AffaMed Therapeutics worth (valuation)?
Valuation information for AffaMed Therapeutics is not publicly available.
Can I buy AffaMed Therapeutics stock?
AffaMed Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AffaMed Therapeutics's last funding round?
AffaMed Therapeutics's most recent funding round was Series B on March 30, 2021.
Who are the main investors in AffaMed Therapeutics?
Key investors in AffaMed Therapeutics include Lake Bleu Capital, CBC Group.
Will AffaMed Therapeutics IPO soon?
No public IPO plans have been announced for AffaMed Therapeutics.
How can I track AffaMed Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in AffaMed Therapeutics's shares on secondary markets.